Maxchemco is a company founded in August 2007 integrating API production, contract research and product marketing. With years of experiences starting from its predecessor in the U. K., we endeavors to provide high-quality APIs, intermediates as well as custom synthesis and services on a cost-effective basis.

We have developed our expertise in both microbiology and chemical syntheses and are able to provide our clients with intermediates production, biological fermentation and synthesis services. For APIs, we are specialized in oncologic drugs like Daunorubicin, Doxorubicin, Epirubicin and Idarubicin. Our capability in microbiology and genetic engineering also allow us to provide a series of amino acids via biological methods.